Mian Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mian Peng has a total of 118 co-authors. Here are the top co-authors by number of shared publications:
Zongze Zhang
Department of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China
17 shared publicationsLei Chen
Department of Anesthesiology Zhongnan Hospital of Wuhan University Wuhan Hubei Province China
15 shared publicationsKe Li
Department of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China
14 shared publicationsYing Zhou
Department of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
10 shared publicationsJiayu Wang
Department of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China
7 shared publicationsYayuan Lu
Department of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China
7 shared publications
Latest Publications
- 31 March 2026
- Published by Bentham Science Publishers Ltd. in Current Neuropharmacology
- Vol. 24 (9) , 1-18
From Bench to Bedside: Understanding General Anesthetics' Impact on PTSD
Post-traumatic stress disorder (PTSD) is a multifaceted mental health disorder arising from exposure to traumatic events, characterized by persistent and distressing symptoms. Recent years have seen growing recognition of anesthesia's dual role in PTSD. While countless patients receive anesthetics during traumatic medical care, their long-term psychological impacts remain unclear, raising urgent clinical questions. This review provides an in-depth analysis of both clinical and animal studies examining the effects of commonly used inhaled and intravenous anesthetics, such as sevoflurane/isoflurane, benzodiazepines (BZDs), ketamine, propofol, and dexmedetomidine (Dex), on PTSD. These studies reveal a complex interplay between these anesthetic agents and PTSD, highlighting their potential to either alleviate or exacerbate symptoms depending on various factors such as dosage, timing, and individual susceptibility. Additionally, this review synthesizes the current understanding of the underlying neurobiological mechanisms through which these anesthetics affect fear memory and neuroplasticity, offering valuable insights into their potential applications and limitations in managing PTSD.
- 31 March 2026
- Published by Bentham Science Publishers Ltd. in Current Neuropharmacology
- Vol. 24 (9) , 1-18
From Bench to Bedside: Understanding General Anesthetics' Impact on PTSD
Post-traumatic stress disorder (PTSD) is a multifaceted mental health disorder arising from exposure to traumatic events, characterized by persistent and distressing symptoms. Recent years have seen growing recognition of anesthesia's dual role in PTSD. While countless patients receive anesthetics during traumatic medical care, their long-term psychological impacts remain unclear, raising urgent clinical questions. This review provides an in-depth analysis of both clinical and animal studies examining the effects of commonly used inhaled and intravenous anesthetics, such as sevoflurane/isoflurane, benzodiazepines (BZDs), ketamine, propofol, and dexmedetomidine (Dex), on PTSD. These studies reveal a complex interplay between these anesthetic agents and PTSD, highlighting their potential to either alleviate or exacerbate symptoms depending on various factors such as dosage, timing, and individual susceptibility. Additionally, this review synthesizes the current understanding of the underlying neurobiological mechanisms through which these anesthetics affect fear memory and neuroplasticity, offering valuable insights into their potential applications and limitations in managing PTSD.
- Open Access
- 17 March 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (4) , 117125
Dexmedetomidine inhibits fear memory consolidation via the astrocyte-specific Srebf1-Phgdh pathway in the prelimbic prefrontal cortex
- 17 March 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (4) , 117125
Open AccessDexmedetomidine inhibits fear memory consolidation via the astrocyte-specific Srebf1-Phgdh pathway in the prelimbic prefrontal cortex
- Open Access
- 1 September 2025
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 21, 2109-2124
Potential Mitochondria-Related Key Genes in Post-Traumatic Stress Disorder Analyzed by Machine Learning Methods
Purpose: Post-traumatic stress disorder (PTSD) is a debilitating psychiatric disorder triggered by exposure to traumatic events. Emerging evidence suggests that mitochondrial dysfunction may contribute to PTSD pathogenesis by disrupting cellular energy metabolism, increasing oxidative stress, and impairing neuroplasticity. This study investigates mitochondrial dysfunction-associated biomarkers, potentially opening new avenues for targeted therapeutic approaches. Methods: Gene expression matrices from datasets GSE199841 and GSE81761 were derived from peripheral blood samples, used to identify differentially expressed genes (DEGs) between PTSD patients and healthy controls. Functional annotation and enrichment analysis were carried out using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses. Next, least absolute shrinkage and selection operator (LASSO), support vector machine recursive feature elimination (SVM-RFE), and random forest were employed to screen and prioritize potential biomarkers, followed by validation through receiver operating characteristic (ROC) analysis and independent cohort from human verification. We also examined the expression of mitoDEGs in peripheral blood from PTSD-related mouse models by RT-qPCR. Given the close interplay between mitochondrial metabolism and immune function, we investigated the relationship between key MitoDEGs and immune infiltration proportions. Results: DEGs in PTSD were enriched in mitochondrial pathways, including mitochondrial ribosome function and nitric oxide synthase regulation. Machine learning identified UCP2, CISD1, NADK2 and IDE as key MitoDEGs. Then we assessed the diagnostic performance of four key genes through ROC curve analysis. We evaluated four key genes using ROC analysis, showing good diagnostic performance in the discovery cohort (AUC=0.871). Results were replicated in validation cohorts (GSE81761 AUC=0.745; GSE97356 AUC=0.638). These genes correlated with immune cell proportions (regulatory T cells, naïve B cells, CD4+/CD8+ T cells) and showed conserved dysregulation in murine blood, aligning with human data. Conclusion: Mitochondrial-related genes UCP2, CISD1, NADK2 and IDE may serve as cross-species diagnostic biomarkers for PTSD, with potential links to neuroimmune mechanisms.
- 1 September 2025
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 21, 2109-2124
Open AccessPotential Mitochondria-Related Key Genes in Post-Traumatic Stress Disorder Analyzed by Machine Learning Methods
Purpose: Post-traumatic stress disorder (PTSD) is a debilitating psychiatric disorder triggered by exposure to traumatic events. Emerging evidence suggests that mitochondrial dysfunction may contribute to PTSD pathogenesis by disrupting cellular energy metabolism, increasing oxidative stress, and impairing neuroplasticity. This study investigates mitochondrial dysfunction-associated biomarkers, potentially opening new avenues for targeted therapeutic approaches. Methods: Gene expression matrices from datasets GSE199841 and GSE81761 were derived from peripheral blood samples, used to identify differentially expressed genes (DEGs) between PTSD patients and healthy controls. Functional annotation and enrichment analysis were carried out using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses. Next, least absolute shrinkage and selection operator (LASSO), support vector machine recursive feature elimination (SVM-RFE), and random forest were employed to screen and prioritize potential biomarkers, followed by validation through receiver operating characteristic (ROC) analysis and independent cohort from human verification. We also examined the expression of mitoDEGs in peripheral blood from PTSD-related mouse models by RT-qPCR. Given the close interplay between mitochondrial metabolism and immune function, we investigated the relationship between key MitoDEGs and immune infiltration proportions. Results: DEGs in PTSD were enriched in mitochondrial pathways, including mitochondrial ribosome function and nitric oxide synthase regulation. Machine learning identified UCP2, CISD1, NADK2 and IDE as key MitoDEGs. Then we assessed the diagnostic performance of four key genes through ROC curve analysis. We evaluated four key genes using ROC analysis, showing good diagnostic performance in the discovery cohort (AUC=0.871). Results were replicated in validation cohorts (GSE81761 AUC=0.745; GSE97356 AUC=0.638). These genes correlated with immune cell proportions (regulatory T cells, naïve B cells, CD4+/CD8+ T cells) and showed conserved dysregulation in murine blood, aligning with human data. Conclusion: Mitochondrial-related genes UCP2, CISD1, NADK2 and IDE may serve as cross-species diagnostic biomarkers for PTSD, with potential links to neuroimmune mechanisms.
- 24 June 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (23) , e2500316
Dissolving Microneedle Patch for Peripheral Delivery of Pregabalin in Neuropathic Pain Management
Neuropathic pain is a complex and debilitating condition that presents substantial challenges for effective treatment, as it often persists despite conventional therapies and can significantly impair the quality of life of affected individuals. Currently, pregabalin is the first‐line treatment for neuropathic pain. However, its oral dosage form is often associated with adverse reactions such as dizziness and drowsiness, and its administration duration is limited, requiring frequent dosing. To address these issues, this study developed a hyaluronic acid (HA)‐based dissolving microneedle (MN) patch incorporating poly (lactic‐co‐glycolic acid) (PLGA) microspheres (MS) loaded with pregabalin (PG) for peripheral administration. The MN array consists of 10 × 10 needles, covering an area of ≈0.5 cm 2 , with each needle having a height of 850 µm. The MN patch demonstrated significant analgesic effects and sustained drug release at the application site for up to 48 h, effectively alleviating pain while minimizing dizziness and drowsiness, which are the most common side effects after systemic administration. This innovative MN platform presents a promising strategy for neuropathic pain management and provides a novel therapeutic paradigm for the peripheral application of centrally acting analgesics.
- 24 June 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (23) , e2500316
Dissolving Microneedle Patch for Peripheral Delivery of Pregabalin in Neuropathic Pain Management
Neuropathic pain is a complex and debilitating condition that presents substantial challenges for effective treatment, as it often persists despite conventional therapies and can significantly impair the quality of life of affected individuals. Currently, pregabalin is the first‐line treatment for neuropathic pain. However, its oral dosage form is often associated with adverse reactions such as dizziness and drowsiness, and its administration duration is limited, requiring frequent dosing. To address these issues, this study developed a hyaluronic acid (HA)‐based dissolving microneedle (MN) patch incorporating poly (lactic‐co‐glycolic acid) (PLGA) microspheres (MS) loaded with pregabalin (PG) for peripheral administration. The MN array consists of 10 × 10 needles, covering an area of ≈0.5 cm 2 , with each needle having a height of 850 µm. The MN patch demonstrated significant analgesic effects and sustained drug release at the application site for up to 48 h, effectively alleviating pain while minimizing dizziness and drowsiness, which are the most common side effects after systemic administration. This innovative MN platform presents a promising strategy for neuropathic pain management and provides a novel therapeutic paradigm for the peripheral application of centrally acting analgesics.
- Open Access
- 23 June 2025
- Published by Wiley in Advanced Science
- Vol. 12 (35) , e03698
Sustained‐Release Photothermal Microneedles for Postoperative Incisional Analgesia and Wound Healing via Hydrogen Therapy
Effective management of postoperative pain and wound healing presents significant challenges in clinical settings, driving the need for innovative therapeutic approaches. The analgesic and wound healing effects of hydrogen (H2) have gradually been recognized; however, the lack of efficient hydrogen delivery systems remains a major limitation. This study introduces a novel transdermal drug delivery system, which utilizes sustained‐release photothermal microneedles (MNs) to ameliorate incisional pain and accelerate wound healing. Polydopamine (PDA)‐modified ZIF‐8@ammonia borane (AB) nanoparticles with photothermal conversion properties are designed, along with temperature‐responsive QX‐314‐loaded polycaprolactone (PCL) microspheres for controlled release, which are delivered in vivo by dissolvable MNs. In vitro results showed that PDA@ZIF‐8@AB nanoparticles can release H2 continuously for up to 5 days in an acidic microenvironment, while the photothermal properties of PDA facilitated controlled release of QX‐314 through 6 cycles of near‐infrared (NIR) exposure. In vivo experiments demonstrated that the MN system provided sustained analgesia for up to 5 days and promoted wound healing in the acidic microenvironment of postoperative incisions. Upon NIR exposure, the photothermal conversion of PDA activated membrane ion channels and induced thermally triggered deformation of PCL@QX‐314 microspheres, allowing for on‐demand release of QX‐314 and targeted neuronal uptake, thus offering personalized analgesia. In vitro cell experiments and in vivo studies confirmed the biocompatibility of the system. This innovative approach not only highlights the dual role of H2 in pain relief and wound healing but also provides a new personalized treatment strategy for postoperative pain management with promising clinical applications.
- 23 June 2025
- Published by Wiley in Advanced Science
- Vol. 12 (35) , e03698
Open AccessSustained‐Release Photothermal Microneedles for Postoperative Incisional Analgesia and Wound Healing via Hydrogen Therapy
Effective management of postoperative pain and wound healing presents significant challenges in clinical settings, driving the need for innovative therapeutic approaches. The analgesic and wound healing effects of hydrogen (H2) have gradually been recognized; however, the lack of efficient hydrogen delivery systems remains a major limitation. This study introduces a novel transdermal drug delivery system, which utilizes sustained‐release photothermal microneedles (MNs) to ameliorate incisional pain and accelerate wound healing. Polydopamine (PDA)‐modified ZIF‐8@ammonia borane (AB) nanoparticles with photothermal conversion properties are designed, along with temperature‐responsive QX‐314‐loaded polycaprolactone (PCL) microspheres for controlled release, which are delivered in vivo by dissolvable MNs. In vitro results showed that PDA@ZIF‐8@AB nanoparticles can release H2 continuously for up to 5 days in an acidic microenvironment, while the photothermal properties of PDA facilitated controlled release of QX‐314 through 6 cycles of near‐infrared (NIR) exposure. In vivo experiments demonstrated that the MN system provided sustained analgesia for up to 5 days and promoted wound healing in the acidic microenvironment of postoperative incisions. Upon NIR exposure, the photothermal conversion of PDA activated membrane ion channels and induced thermally triggered deformation of PCL@QX‐314 microspheres, allowing for on‐demand release of QX‐314 and targeted neuronal uptake, thus offering personalized analgesia. In vitro cell experiments and in vivo studies confirmed the biocompatibility of the system. This innovative approach not only highlights the dual role of H2 in pain relief and wound healing but also provides a new personalized treatment strategy for postoperative pain management with promising clinical applications.
- 17 July 2024
- Published by Elsevier in Sleep Medicine
- Vol. 121, 287-294
Effect of desflurane maintenance on postoperative sleep quality in patients undergoing elective breast surgery: A non-inferiority randomized controlled trial
- 17 July 2024
- Published by Elsevier in Sleep Medicine
- Vol. 121, 287-294
Effect of desflurane maintenance on postoperative sleep quality in patients undergoing elective breast surgery: A non-inferiority randomized controlled trial
- 10 December 2023
- Published by Wiley in Advanced Functional Materials
- Vol. 34 (12)
A pH‐Responsive Core‐Shell Microneedle Patch with Self‐Monitoring Capability for Local Long‐Lasting Analgesia
Postoperative pain, as a common and significant healthcare issue, has always been the focus of attention in the field of anesthesia for its control and treatment. In the present study, a pH‐responsive microneedle (MN) patch is developed for sustained incisional analgesia after surgery. The MN patch has a 10 × 10 MN array within 0.5 cm2 area, and each MN features a complete core‐shell structure, with a needle height of ≈850 µm. Upon application, the MNs fully implant in the skin within 15 min due to the rapid dissolution of the water‐soluble backing layer. The acidic microenvironment at the surgical site (pH 6.8–7.0) interacts with the pH‐reactive medium in the MN shell, triggering the shell rupture. This process enables the smooth release of encapsulated local anesthetic drug (Ropivacaine, Rop) microcrystals, extending local anesthesia duration to over 72 h at a drug concentration of 100 mg mL−1. Additionally, the MN patch intelligently modulates drug release based on the postoperative pain behavior, which correlates with the pH value of the surgical incision microenvironment. This responsive feature results in a prolonged and personalized analgesic effect, addressing the limitations of existing invasive treatments in postoperative pain management.
- 10 December 2023
- Published by Wiley in Advanced Functional Materials
- Vol. 34 (12)
A pH‐Responsive Core‐Shell Microneedle Patch with Self‐Monitoring Capability for Local Long‐Lasting Analgesia
Postoperative pain, as a common and significant healthcare issue, has always been the focus of attention in the field of anesthesia for its control and treatment. In the present study, a pH‐responsive microneedle (MN) patch is developed for sustained incisional analgesia after surgery. The MN patch has a 10 × 10 MN array within 0.5 cm2 area, and each MN features a complete core‐shell structure, with a needle height of ≈850 µm. Upon application, the MNs fully implant in the skin within 15 min due to the rapid dissolution of the water‐soluble backing layer. The acidic microenvironment at the surgical site (pH 6.8–7.0) interacts with the pH‐reactive medium in the MN shell, triggering the shell rupture. This process enables the smooth release of encapsulated local anesthetic drug (Ropivacaine, Rop) microcrystals, extending local anesthesia duration to over 72 h at a drug concentration of 100 mg mL−1. Additionally, the MN patch intelligently modulates drug release based on the postoperative pain behavior, which correlates with the pH value of the surgical incision microenvironment. This responsive feature results in a prolonged and personalized analgesic effect, addressing the limitations of existing invasive treatments in postoperative pain management.
- 26 May 2023
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 23 (13) , 3002-3015
Bioengineering of a human physiologically relevant microfluidic blood–cerebrospinal fluid barrier model
We demonstrate a bioengineered humanized BCSFB model on a microfluidic device. This model recapitulates structural and functional features of BCSFB in both physiological and neuroinflammatory situations, and may be a potential tool for BCSFB study.
- 26 May 2023
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 23 (13) , 3002-3015
Bioengineering of a human physiologically relevant microfluidic blood–cerebrospinal fluid barrier model
We demonstrate a bioengineered humanized BCSFB model on a microfluidic device. This model recapitulates structural and functional features of BCSFB in both physiological and neuroinflammatory situations, and may be a potential tool for BCSFB study.
- 16 December 2022
- Published by Wiley in Journal of Neurochemistry
- Vol. 164 (5) , 684-699
Role of adenosine A2A receptors in the loss of consciousness induced by propofol anesthesia
The mechanism of propofol-anesthesia-induced loss of consciousness (LOC) remains largely unknown. We speculated that the adenosine A(2A) receptor serves as a vital molecular target in regulating LOC states under propofol anesthesia. c-Fos staining helped observe the changes in the neuronal activity in the nucleus accumbens (NAc). Initially, the adenosine signals in the NAc were measured under propofol anesthesia using fiber photometry recordings. Then, behavior tests and electrophysiological recordings were used to verify the effect of systemic A(2A)R agonist or antagonist treatment on propofol anesthesia. Next, the microinjection technique was used to clarify the role of the NAc A(2A)R under propofol anesthesia. Fiber photometry recordings were applied to assess the effect of A(2A)R agonist or antagonist systemic treatment on adenosine signal alterations in the NAc during propofol anesthesia. Then, as the GABAergic neurons are the main neurons in the NAc, we further measured the neuronal activity of GABAergic neurons. In our study, propofol anesthesia enhanced the neuronal activity in the NAc, and the adenosine signals were increased in the NAc. SCH58261 reduced the LOC time and sedative depth, while CGS21680 increased those via intraperitoneal injection. Additionally, CGS21680 increased the changes in delta, theta, alpha, beta, and low-gamma oscillations in the NAc. Moreover, microinjection of SCH58261 significantly shortened the LOC time, whereas microinjection of CGS21680 into the NAc significantly prolonged the LOC duration. The results illustrated that after A(2A)R agonist administration, the level of extracellular adenosine signals in the NAc was decreased and the neuronal activity of GABAergic neurons was enhanced, whereas after A(2A)R antagonist administration via intraperitoneal injection, the opposite occurred. This study reveals the vital role of the A(2A)R in propofol-induced LOC and that the A(2A)R could affect the maintenance of propofol anesthesia.
- 16 December 2022
- Published by Wiley in Journal of Neurochemistry
- Vol. 164 (5) , 684-699
Role of adenosine A2A receptors in the loss of consciousness induced by propofol anesthesia
The mechanism of propofol-anesthesia-induced loss of consciousness (LOC) remains largely unknown. We speculated that the adenosine A(2A) receptor serves as a vital molecular target in regulating LOC states under propofol anesthesia. c-Fos staining helped observe the changes in the neuronal activity in the nucleus accumbens (NAc). Initially, the adenosine signals in the NAc were measured under propofol anesthesia using fiber photometry recordings. Then, behavior tests and electrophysiological recordings were used to verify the effect of systemic A(2A)R agonist or antagonist treatment on propofol anesthesia. Next, the microinjection technique was used to clarify the role of the NAc A(2A)R under propofol anesthesia. Fiber photometry recordings were applied to assess the effect of A(2A)R agonist or antagonist systemic treatment on adenosine signal alterations in the NAc during propofol anesthesia. Then, as the GABAergic neurons are the main neurons in the NAc, we further measured the neuronal activity of GABAergic neurons. In our study, propofol anesthesia enhanced the neuronal activity in the NAc, and the adenosine signals were increased in the NAc. SCH58261 reduced the LOC time and sedative depth, while CGS21680 increased those via intraperitoneal injection. Additionally, CGS21680 increased the changes in delta, theta, alpha, beta, and low-gamma oscillations in the NAc. Moreover, microinjection of SCH58261 significantly shortened the LOC time, whereas microinjection of CGS21680 into the NAc significantly prolonged the LOC duration. The results illustrated that after A(2A)R agonist administration, the level of extracellular adenosine signals in the NAc was decreased and the neuronal activity of GABAergic neurons was enhanced, whereas after A(2A)R antagonist administration via intraperitoneal injection, the opposite occurred. This study reveals the vital role of the A(2A)R in propofol-induced LOC and that the A(2A)R could affect the maintenance of propofol anesthesia.